Observational studyDrugs & aging2026
Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients.
Javier Loricera et al.PubMed ↗Publisher ↗
No numbers read from the abstract.